These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27097163)

  • 1. Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer.
    Barogui YT; Klis SA; Johnson RC; Phillips RO; van der Veer E; van Diemen C; van der Werf TS; Stienstra Y
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004594. PubMed ID: 27097163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection.
    Nienhuis WA; Stienstra Y; Abass KM; Tuah W; Thompson WA; Awuah PC; Awuah-Boateng NY; Adjei O; Bretzel G; Schouten JP; van der Werf TS
    Clin Infect Dis; 2012 Feb; 54(4):519-26. PubMed ID: 22156855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism.
    Stienstra Y; van der Werf TS; Oosterom E; Nolte IM; van der Graaf WT; Etuaful S; Raghunathan PL; Whitney EA; Ampadu EO; Asamoa K; Klutse EY; te Meerman GJ; Tappero JW; Ashford DA; van der Steege G
    Genes Immun; 2006 Apr; 7(3):185-9. PubMed ID: 16395392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Variation in Autophagy-Related Genes Influences the Risk and Phenotype of Buruli Ulcer.
    Capela C; Dossou AD; Silva-Gomes R; Sopoh GE; Makoutode M; Menino JF; Fraga AG; Cunha C; Carvalho A; Rodrigues F; Pedrosa J
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004671. PubMed ID: 27128681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load.
    Frimpong M; Agbavor B; Duah MS; Loglo A; Sarpong FN; Boakye-Appiah J; Abass KM; Dongyele M; Amofa G; Tuah W; Frempong M; Amoako YA; Wansbrough-Jones M; Phillips RO
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007689. PubMed ID: 31449522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection.
    Wanda F; Nkemenang P; Ehounou G; Tchaton M; Comte E; Toutous Trellu L; Masouyé I; Christinet V; O'Brien DP
    BMC Infect Dis; 2014 Jul; 14():423. PubMed ID: 25073531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Inflammatory Markers in Patients Treated for Buruli Ulcer and Their Ability to Predict Paradoxical Reactions.
    Phelippeau M; Marion E; Robbe-Saule M; Ganlanon L; Chauty A; Adeye A; Blanchard S; Johnson C; Marsollier L; Dubee V
    J Infect Dis; 2023 Nov; 228(11):1630-1639. PubMed ID: 37221015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
    Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC11A1 (Formerly NRAMP1) gene polymorphisms associated with pediatric tuberculosis in China.
    Jin J; Sun L; Jiao W; Zhao S; Li H; Guan X; Jiao A; Jiang Z; Shen A
    Clin Infect Dis; 2009 Mar; 48(6):733-8. PubMed ID: 19193106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in human
    Fevereiro J; Fraga AG; Capela C; Sopoh GE; Dossou A; Ayelo GA; Peixoto MJ; Cunha C; Carvalho A; Rodrigues F; Pedrosa J
    Emerg Microbes Infect; 2021 Dec; 10(1):223-225. PubMed ID: 33467983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on the haplotype of the solute carrier family 11 member 1 gene in Tibetan patients with pulmonary tuberculosis in China].
    Chen XR; Feng YL; Ma Y; Zhang ZD; Li CY; Wen FQ; Tang XY; Su ZG
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 May; 32(5):360-4. PubMed ID: 19799071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
    Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
    Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges associated with the treatment of Buruli ulcer.
    Aboagye SY; Kpeli G; Tuffour J; Yeboah-Manu D
    J Leukoc Biol; 2019 Feb; 105(2):233-242. PubMed ID: 30168876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
    Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
    Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human genetics of Buruli ulcer.
    Manry J
    Hum Genet; 2020 Jun; 139(6-7):847-853. PubMed ID: 32266523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.
    O'Brien DP; Robson M; Friedman ND; Walton A; McDonald A; Callan P; Hughes A; Rahdon R; Athan E
    BMC Infect Dis; 2013 Sep; 13():416. PubMed ID: 24007371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRAMP1/SLC11A1 gene polymorphisms and host susceptibility to Mycobacterium tuberculosis and M. leprae in South Sulawesi, Indonesia.
    Hatta M; Ratnawati ; Tanaka M; Ito J; Shirakawa T; Kawabata M
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):386-94. PubMed ID: 20578522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
    Gyamfi E; Narh CA; Quaye C; Abbass A; Dzudzor B; Mosi L
    BMC Microbiol; 2021 Jan; 21(1):4. PubMed ID: 33402095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
    Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
    Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case-control study on natural-resistance-associated macrophage protein 1 gene polymorphisms and susceptibility to pulmonary tuberculosis].
    Liu W; Zhang CY; Tian L; Li CZ; Wu XM; Zhao QM; Zhang PH; Yang SM; Yang H; Cao WC
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Nov; 37(6):408-11. PubMed ID: 14703493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.